Literature DB >> 14736068

Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.

Amelia M Simpson1, Lori L Ludwig, Shelley J Newman, Philip J Bergman, Heidi A Hottinger, Amiya K Patnaik.   

Abstract

OBJECTIVE: To determine whether neoplastic mast cells extended into tissue 1, 2, or 3 cm laterally or deeper than 1 fascial plane from the visible edge of cutaneous mast cell tumors (MCTs) in dogs.
DESIGN: Prospective study. ANIMALS: 21 client-owned dogs with > or = 1 cutaneous MCT PROCEDURES: After preparation for surgery, each dog's skin was marked 1, 2, and 3 cm from the tumor edge at 0 degrees, 90 degrees, 180 degrees, and 270 degrees. At each 3-cm mark, deep fascia was exposed and sutured to the skin; the tumor was excised in routine fashion and fixed in formalin. Tumors were graded; margins were examined histologically for neoplastic mast cells.
RESULTS: 23 cutaneous MCTs in 21 dogs were included in this study. Fifteen (65%) tumors were located on the trunk, 5 (22%) on the hind limbs, and 3 (13%) on the head and neck. There were 3 (13%) grade-I and 20 (87%) grade-II tumors. All grade-I tumors were completely excised at all margins. Seventy-five percent of the grade-II tumors were completely excised at the 1-cm margin, and 100% were completely excised at the 2-cm margin. Two grade-II MCTs located on the hind limbs of dogs were excised with a complete but close (within 1 mm) deep margin. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that a 2-cm lateral margin and a deep margin of 1 fascial plane appear to be adequate for complete excision of grade-I and -II MCTs in dogs.

Entities:  

Mesh:

Year:  2004        PMID: 14736068     DOI: 10.2460/javma.2004.224.236

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  15 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  Intramuscular mast cell tumors in 7 dogs.

Authors:  William P Robinson; James Elliott; Stephen J Baines; Laura Owen; Chris J Shales
Journal:  Can Vet J       Date:  2017-09       Impact factor: 1.008

3.  Predictive ability of fine-needle aspirate cytology for incompletely resected mast cell tumor surgical sites.

Authors:  Christopher E Lee; Stephanie S Lindley; Annette N Smith; Philippe Gaillard; Ralph A Henderson; Brad M Matz
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

4.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

5.  Evaluation of the effect of formalin fixation on skin specimens in dogs and cats.

Authors:  Jaimie L Miller; Michael J Dark
Journal:  PeerJ       Date:  2014-03-13       Impact factor: 2.984

6.  Evaluation of the extent of neoplastic infiltration in small intestinal tumours in dogs.

Authors:  Michael Morrice; Gerry Polton; Sam Beck
Journal:  Vet Med Sci       Date:  2019-02-19

7.  Evaluation of the histopathological extent of neoplastic infiltration in intestinal tumours in cats.

Authors:  Michael Morrice; Gerry Polton; Sam Beck
Journal:  Vet Med Sci       Date:  2019-03-11

8.  Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high-risk canine mast cell tumours to tyrosine kinase inhibitors.

Authors:  Rodrigo Dos Santos Horta; Antonio Giuliano; Gleidice Eunice Lavalle; Mariana de Pádua Costa; Roberto Baracat de Araújo; Fernando Constantino-Casas; Jane Margaret Dobson
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

9.  A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.

Authors:  Laura E Selmic; Audrey Ruple
Journal:  BMC Vet Res       Date:  2020-01-06       Impact factor: 2.741

10.  Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate.

Authors:  Pamela D Jones; Justine E Campbell; Graham Brown; Chad M Johannes; Paul Reddell
Journal:  J Vet Intern Med       Date:  2020-12-22       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.